GAMMA Investing LLC Purchases 72 Shares of HCA Healthcare, Inc. (NYSE:HCA)

GAMMA Investing LLC grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,086 shares of the company’s stock after purchasing an additional 72 shares during the period. GAMMA Investing LLC’s holdings in HCA Healthcare were worth $362,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Stone House Investment Management LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $25,000. Centerpoint Advisors LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $27,000. Atlantic Edge Private Wealth Management LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $27,000. Bruce G. Allen Investments LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $28,000. Finally, FinTrust Capital Advisors LLC increased its holdings in HCA Healthcare by 26.7% during the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after purchasing an additional 35 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA stock opened at $340.64 on Thursday. The stock’s 50 day simple moving average is $321.65 and its 200 day simple moving average is $314.33. The stock has a market capitalization of $89.22 billion, a PE ratio of 16.98, a price-to-earnings-growth ratio of 1.58 and a beta of 1.69. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $343.53.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.01 by $0.35. The firm had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company’s revenue was up 11.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.93 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be paid a $0.66 dividend. The ex-dividend date is Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.78%. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Wells Fargo & Company boosted their price target on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a report on Thursday, March 28th. Cantor Fitzgerald reiterated an “overweight” rating and set a $335.00 target price on shares of HCA Healthcare in a report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft upped their target price on HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a report on Friday, April 12th. Finally, StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Sunday. Four analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $325.59.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jeffrey E. Cohen sold 1,650 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the sale, the senior vice president now owns 5,185 shares in the company, valued at approximately $1,622,905. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, SVP Jeffrey E. Cohen sold 1,650 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $313.00, for a total transaction of $516,450.00. Following the completion of the transaction, the senior vice president now owns 5,185 shares in the company, valued at $1,622,905. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kathryn A. Torres sold 1,863 shares of the firm’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total value of $607,673.34. Following the transaction, the senior vice president now owns 19,612 shares of the company’s stock, valued at approximately $6,397,042.16. The disclosure for this sale can be found here. In the last quarter, insiders sold 12,397 shares of company stock worth $3,921,929. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.